Cromatina / Epigenética
Los inhibidores de cromatina/epigenética son compuestos que modulan la estructura y función de la cromatina o interfieren con modificaciones epigenéticas, como la metilación del ADN y la modificación de histonas. Estos inhibidores son herramientas esenciales para estudiar la regulación de la expresión génica y el papel de la epigenética en enfermedades como el cáncer, los trastornos neurológicos y las anomalías del desarrollo. Al dirigirse a los procesos epigenéticos, estos inhibidores pueden alterar los patrones de expresión génica y ofrecer nuevas vías terapéuticas. En CymitQuimica, ofrecemos una amplia selección de inhibidores de cromatina/epigenética de alta calidad para apoyar su investigación en biología molecular, genética y epigenética.
Subcategorías de "Cromatina / Epigenética"
Se han encontrado 2245 productos de "Cromatina / Epigenética"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
CBP/p300-IN-19
CAS:CBP/p300-IN-19 inhibits p300/CBP HAT (IC50: 1.4μM), less effective on PCAF/Myst3, shows anti-tumor properties.Fórmula:C30H27N3O3Forma y color:SolidPeso molecular:477.55Gö 7874
CAS:<p>Gö 7874 is a potent, reversible, ATP-competitive, and selective inhibitor of protein kinase C (IC50 = 4 nM for rat brain PKC).</p>Fórmula:C27H26N4O4Forma y color:SolidPeso molecular:470.52GSK761
<p>GSK761 inhibits SP140 (IC50: 77.79 nM), hinders monocyte-to-macrophage differentiation, and prompts CD206+ regulatory macrophages.</p>Fórmula:C40H46N4O4Forma y color:SolidPeso molecular:646.82CBB1007 hydrochloride
CAS:<p>CBB1007 Hcl inhibits LSD1 selectively (IC50=5.27μM), blocks H3K4 demethylation, activates genes; less effect on other cells/tissues.</p>Fórmula:C27H39Cl5N8O4Forma y color:SoildPeso molecular:716.91KH-3
CAS:<p>KH-3: HuR inhibitor, IC50 0.35 μM, halts cell growth, blocks HuR-FOXQ1 mRNA, curbs breast cancer invasion, slows lung colony growth.</p>Fórmula:C21H22N2O4S2Forma y color:SolidPeso molecular:430.54CCT129202
CAS:<p>CCT129202 is an ATP-competitive pan-Aurora inhibitor for Aurora A, Aurora B and Aurora C with IC50 of 0.042 μM, 0.198 μM and 0.227 μM, respectively.</p>Fórmula:C23H25ClN8OSPureza:98.14%Forma y color:SolidPeso molecular:497.02NPAS3-IN-1
CAS:<p>NPAS3-IN-1 is an NPAS3-ARNT heterodimerization inhibitor that regulates NPAS3 transcription by modulating the heterodimerization of NPAS3 with ARNT.</p>Fórmula:C10H5N3O2S3Pureza:99.56%Forma y color:SolidPeso molecular:295.36FHT-1015
CAS:<p>FHT-1205 is a potent inhibitor (IC50 ≤ 10 nM) of SMARCA4/SMARCA2 ATPase (BRG1 and BRM).</p>Fórmula:C25H25N5O4S3Pureza:98.57%Forma y color:SolidPeso molecular:555.69GNE-375
CAS:<p>GNE-375 is a selective and potent BRD9 inhibitor (IC50: 5 nM).GNE-375 inhibits BRD4, TAF1, and CECR2, and can be used to study epigenetic resistance.</p>Fórmula:C25H29N3O5Pureza:98.99%Forma y color:SolidPeso molecular:451.51CPI-0610 carboxylic acid
CAS:<p>CPI-0610 carboxylic acid is a selective BET protein inhibitor with potential anticancer effects.</p>Fórmula:C20H15ClN2O3Pureza:98.62%Forma y color:SolidPeso molecular:366.8LY3295668
CAS:<p>LY3295668 (AK-01) is a selective inhibitor of Aurora A with Kis of 0.8 nM and 1038 nM for Aurora A and B, respectively.</p>Fórmula:C24H26ClF2N5O2Pureza:99.68%Forma y color:SolidPeso molecular:489.95HS94
CAS:<p>HS94 (DAPK3 inhibitor HS94) is a selective and potent DAPK3 inhibitor with a Ki value of 126 nM for Pim kinase inhibition and can be used to study hypertension.</p>Fórmula:C15H15N5O2SPureza:95.04%Forma y color:SolidPeso molecular:329.38EPZ031686
CAS:<p>EPZ031686 is an effective inhibitor of SMYD3 inhibitor with an IC50 of 3 nM and can be used in studies about cancer.</p>Fórmula:C26H34ClF3N4O4SPureza:99.67%Forma y color:SolidPeso molecular:591.09HIF-2α agonist 2
CAS:HIF-2α agonist 2 is an HIF-2α agonist with an EC50 value of 1.68 μM for HIF-2α.Fórmula:C13H8Br2N2O2SPureza:98.87%Forma y color:SoildPeso molecular:416.09hRIO2 kinase ligand-1
CAS:hRIO2 kinase ligand-1 is a potent ligand for hRIO2 kinase (Kd: 520 nM).Fórmula:C17H14N2OPureza:99.89%Forma y color:SolidPeso molecular:262.31PARP-1-IN-4
CAS:<p>PARP-1-IN-4 is a potent PARP-1 inhibitor with potential see anti-tumor activity, and inhibition of PARP-1 may be used in cancer development.</p>Fórmula:C22H15Cl2N3O2Pureza:99.82%Forma y color:SolidPeso molecular:424.28KDM4-IN-4
CAS:<p>KDM4-IN-4 is a KDM4 inhibitor with anticancer activity that inhibits the KDM4A-Tudor structural domain for cancer research.</p>Fórmula:C16H23NOPureza:99.61%Forma y color:SolidPeso molecular:245.36JAK-IN-3
CAS:<p>JAK-IN-3 is a potent JAK inhibitor that inhibits JAK3, JAK1, TYK2, and JAK2, and can be used for the study of immune system disorders.</p>Fórmula:C18H20N4O3Pureza:98.04% - 98.19%Forma y color:SolidPeso molecular:340.38E7016
CAS:<p>E7016 (GPI 21016) is an orally available PARP inhibitor. E7016 inhibits of DNA repair. E7016 can enhance tumor cell radiosensitivity in vitro and in vivo.</p>Fórmula:C20H19N3O3Pureza:99.02%Forma y color:SolidPeso molecular:349.38AU-15330
CAS:<p>AU-15330 is a proteolytic targeting chimera (PROTAC) that simultaneously targets SMARCA4, SMARCA2, and PBRM1 for degradation and exhibits cytotoxicity in H3.3K27M cells but not in H3 wild-type cells. Cost-effective and quality-assured.</p>Fórmula:C39H49N9O5SPureza:98.21% - 99.62%Forma y color:SolidPeso molecular:755.93
